Activision Blizzard (NASDAQ:ATVI), Electronic Arts (NASDAQ:EA), and Take Two Interactive (NASDAQ:TTWO) have each launched professional esports leagues this year, while advertising and sponsorships are expected to make up three-quarters of the industry’s nearly $1 billion of revenue. And the recent announcement that Nielsen Holdings (NYSE:NLSN) will apply its TV rating expertise to Activision’s esport events could be the catalyst that unleashes a floodgate of media buying.
In this segment from Industry Focus: Consumer Goods, the cast discusses these latest developments and more.
A full transcript follows the video.
This video was recorded on May 22, 2018.
Vincent Shen: Investors are pretty fortunate with video games in that there are quite a few publicly traded companies targeting the esports opportunity. They also happen to be some of the leading names in the industry.
A lot of our listeners have probably heard of Activision Blizzard, ticker ATVI; Electronic Arts, ticker EA; Take-Two Interactive, ticker TTWO. Across the board, we’re seeing esports come up more and more in these companies’ press releases and their earnings calls. I’m going to share a few quotes from management teams. It’s not like I had to go digging to find these examples — these are all from the most recent quarterly investor calls.
Hot Low Price Stocks To Watch Right Now: TGC Industries Inc.(TGE)
TGC Industries, Inc. provides geophysical services for clients in the oil and gas business in the United States and Canada. It conducts three-D surveys and seismic data acquisition services primarily to onshore oil and natural gas exploration and development companies for use in the onshore drilling and production of oil and natural gas. The company also owns a data bank that contains gravity data and magnetic data from oil and natural gas producing areas located in the United States. It operates 8 seismic crews in the lower 48 states in the United States, as well as 2 crews in Canada. The company was formerly known as Tidelands Geophysical Co., Inc. and changed its name to TGC Industries, Inc. in July 1986. TGC Industries, Inc. was founded in 1967 and is headquartered in Plano, Texas.
- [By Matthew DiLallo]
Tallgrass Energy (NYSE:TGE) currently boasts the biggest payout in this group at 8.9%. The pipeline company can easily support that big dividend since it generates very stable cash flow backed by long-term contracts, has a conservative payout ratio, and has a solid balance sheet. However, what makes Tallgrass Energy even more enticing is its growth prospects. The company currently has three large-scale oil infrastructure investments under development, which could fuel significant growth in the coming years. As such, investors are getting paid very well to wait for that upside to materialize.
- [By Stephan Byrd]
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 14th. Stockholders of record on Thursday, January 31st were given a $0.52 dividend. The ex-dividend date was Wednesday, January 30th. This is an increase from Tallgrass Energy’s previous quarterly dividend of $0.51. This represents a $2.08 dividend on an annualized basis and a dividend yield of 9.11%. Tallgrass Energy’s dividend payout ratio is currently 163.78%.
ILLEGAL ACTIVITY NOTICE: “Ffcm LLC Takes $38,000 Position in Tallgrass Energy LP (TGE)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at www.tickerreport.com/banking-finance/4195528/ffcm-llc-takes-38000-position-in-tallgrass-energy-lp-tge.html.
About Tallgrass Energy
Hot Low Price Stocks To Watch Right Now: Nymox Pharmaceutical Corporation(NYMX)
Nymox Pharmaceutical Corporation, incorporated on May 30, 1995, is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also has a range of patent portfolio covering its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer’s disease. The Company’s subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
The Company’s NicAlert and TobacAlert are the test strips, which determine whether a person is using tobacco products (NicAlert) or has been exposed to second-hand smoke (TobacAlert). Both NicAlert and TobacAlert provide a read-out of levels of cotinine, a by-product of the body’s breakdown of nicotine and regarded as the indicator of tobacco exposure for smokers and non-smokers. The technology can be used with saliva, as well as urine samples in order to detect tobacco product use. The Company’s AlzheimAlert is a urine assay that can aid physicians in the diagnosis of Alzheimer’s disease. The Company has developed a kit version of the AlzheimAlert assay for sale in Europe. The kit allows clinical reference laboratories to perform the AlzheimAlert assay on site with urine samples sent directly to the laboratory.
The Company is developing treatments for BPH. The Company’s lead candidate NX-1207 completed a multi-center, double-blind, placebo-controlled Phase II trial. The ! Company is in the process of further data analysis and assessments of the two studies. The Company is also developing NX-1207 as a focal treatment for certain types of cancer. The Company initiated a Phase II clinical trial in the United States. The Company enrolled approximately 147 patients at over 28 clinical centers across the United States to evaluate its NX-1207 drug for the treatment of low-grade localized prostate cancer.
The Company competes with LabCorp, Quest Diagnostics, OraSure Technologies Inc., Abraxis LLC, Roche Diagnostics, Abbott, Siemens Medical Solutions, Mossman & Associates Ltd, GFC Diagnostics Ltd., Lilly and GE Healthcare.
- [By Logan Wallace]
IDEXX Laboratories (NASDAQ: IDXX) and Nymox Pharmaceutical (NASDAQ:NYMX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.
Hot Low Price Stocks To Watch Right Now: Scorpio Tankers Inc.(STNG)
Scorpio Tankers Inc. provides marine transportation of crude oil and refined petroleum products worldwide. As of April 26, 2011, it owned one LR2 tanker, four LR1 tankers, four Handymax tankers, and one post-Panamax tanker, as well as chartered one LR1 and four Handymax product tankers. The company was founded in 2009 and is based in Monaco, Monaco.
- [By Stephan Byrd]
WARNING: “Boston Partners Decreases Holdings in Scorpio Tankers Inc. (STNG)” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at www.tickerreport.com/banking-finance/4180102/boston-partners-decreases-holdings-in-scorpio-tankers-inc-stng.html.
- [By Motley Fool Transcribers]
Scorpio Tankers Inc (NYSE:STNG)Q42018 Earnings Conference CallFeb. 14, 2019, 8:30 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Stephan Byrd]
Scorpio Tankers Inc. (NYSE:STNG)’s share price reached a new 52-week low during trading on Friday . The company traded as low as $1.78 and last traded at $1.78, with a volume of 151745 shares traded. The stock had previously closed at $1.80.
- [By Joseph Griffin]
Scorpio Tankers Inc. (NYSE:STNG) gapped down before the market opened on Thursday . The stock had previously closed at $1.75, but opened at $1.82. Scorpio Tankers shares last traded at $1.81, with a volume of 169888 shares traded.
Hot Low Price Stocks To Watch Right Now: Cache Inc.(CACH)
Cache, Inc., together with its subsidiaries, operates as a mall and Web based specialty retailer of women?s lifestyle sportswear and dresses in the United States. It offers eveningwear; casual and daytime sportswear, including tops, bottoms, and dresses; and accessories, such as jewelry, belts, and handbags under the Cache brand name. The company also provides its products online through its Web site, cache.com. As of March 22, 2012, it operated 267 stores in 43 states, Puerto Rico, and the U.S. Virgin Islands. Cache, Inc. was founded in 1975 and is headquartered in New York, New York.
- [By Max Byerly]
Cache (OTCMKTS: CACH) and New York & Company, Inc. (NYSE:NWY) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.
- [By Shane Hupp]
CacheCoin (CACH) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on January 5th, 2014. CacheCoin’s total supply is 4,195,132 coins. CacheCoin’s official Twitter account is @CACHeCoin. The Reddit community for CacheCoin is /r/cachecoin and the currency’s Github account can be viewed here. The official website for CacheCoin is www.cachecoin.cc.
Hot Low Price Stocks To Watch Right Now: Evertec, Inc.(EVTC)
EVERTEC, Inc., formerly Carib Latam Holdings, Inc., incorporated on April 13, 2012, is a full-service transaction processing company. The Company provides a range of merchant acquiring, payment processing and business process management services across approximately 20 countries. The Company operates through three segments: Merchant Acquiring, Payment Processing and Business Solutions. The Company owns and operates the ATH network, an automated teller machine (ATM) and personal identification number (PIN) debit network in Latin America. In addition, the Company provides a range of services for core bank processing, cash processing and technology outsourcing in the regions it serves. The Company serves a diversified customer base of financial institutions, merchants, corporations and government agencies with solutions that enable them to issue, process and accept transactions securely. It manages a system of electronic payment networks that process approximately two billion transactions annually. The Company’s suite of services spans the entire transaction processing value chain and includes a range of front-end customer-facing solutions, such as the electronic capture and authorization of transactions at the point-of-sale (POS), as well as back-end support services, such as the clearing and settlement of transactions and account reconciliation for card issuers.
The Company’s merchant acquiring business provides services to merchants that allow them to accept electronic methods of payment, such as debit, credit, prepaid and electronic benefit transfer (EBT) cards, carrying the ATH, Visa, MasterCard, Discover and American Express brands. Its suite of merchant acquiring services includes the underwriting of each merchant’s contract, the deployment and rental of POS devices and other equipment necessary to capture merchant transactions, the processing of transactions at the POS, the settlement of funds with the participating financial institution, detailed sale! s reports and customer support.
The Company is a card processor and network services provider in the Caribbean. It provides a suite of payment processing products and services to blue chip regional and global corporate customers, government agencies and financial institutions across Latin American and the Caribbean. These services provide the infrastructure technology necessary to facilitate the processing and routing of payments across the transaction processing value chain. At the POS, it sells transaction processing technology solutions to other merchant acquirers to enable them to service its own merchant customers. It also offers terminal driving solutions to merchants, merchant acquirers (including its merchant acquiring business) and financial institutions, which provide the technology to operate, manage and monitor POS terminals and ATMs. It also rents POS devices to financial institution customers who seek to deploy them across their own businesses.
The ATH network connects the merchant or merchant acquirer to the card issuer and enables transactions to be routed or switched across the transaction processing value chain. The ATH network offers the technology, communications standards, rules and procedures, security and encryption, funds settlement and common branding that allow consumers, merchants, merchant acquirers, ATMs, card issuer processors and card issuers to conduct commerce across a range of channels. To enable financial institutions, governments and other businesses to issue and operate a range of payment products and services, it offers a range of card processing and other payment technology services, such as Internet and mobile banking software services, bill payment systems and EBT solutions. Financial institutions and certain retailers outsource to the Company certain card processing services, such as card issuance, processing card applications, cardholder account maintenance, transaction authorization and posting, fraud a! nd risk m! anagement services, and settlement. Its payment products include electronic check processing, automated clearing house (ACH), lockbox, online, interactive voice response and Web-based payments through personalized Websites, among others. Its EBT application allows certain agencies to deliver government benefits to participants through a magnetic card system and serves over 7,80,000 active participants.
The Company provides its financial institution, corporate and government customers with a suite of business process management solutions. These solutions include core bank processing, network hosting and management, information technology (IT) consulting services, business process outsourcing, item and cash processing, and fulfillment.
The Company competes with Vantiv, Inc., First Data Corporation, Global Payments Inc., Elavon, Inc., Sage Payment Solutions, Fidelity National Information Services, Inc., Fiserv, Inc., Total System Services, Inc., MasterCard, Visa, American Express and Discover.
- [By Ethan Ryder]
Shares of Evertec Inc (NYSE:EVTC) have been assigned an average rating of “Hold” from the twelve analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $23.20.
- [By ]
3. Evertec (NYSE: EVTC)
A Puerto Rico-based payment processor that has soared by over 75% this year but maintains a forward P/E around 14, placing the shares firmly in the value category.
- [By Matthew Cochrane]
Which individual stocks in the ETF’s portfolio have done the heaviest lifting? This year, so far, that honor belongs to First Data Corp. (NYSE:FDC), Evertec Inc. (NYSE:EVTC), and Square Inc. (NYSE:SQ). That’s after screening for companies in the fund’s portfolio that trade on a domestic stock exchange and have a market cap greater than $1 billion. Let’s take a closer look at all three to see why these companies’ stocks have appreciated so far this year.
- [By Shane Hupp]
Equities research analysts at Raymond James initiated coverage on shares of Evertec (NYSE:EVTC) in a report released on Friday, MarketBeat reports. The firm set a “market perform” rating on the business services provider’s stock.
Hot Low Price Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.
- [By Motley Fool Transcribers]
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)Q42018 Earnings Conference CallMarch 04, 2019, 8:30 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Shane Hupp]
Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Maxx Chatsko]
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) rose over 21% last month, according to data provided by S&P Global Market Intelligence. In the beginning of the month, the company announced the successful sale of 10.4 million shares that raised around $57.5 million in gross proceeds.